SRRM2 and obesity due to melanocortin 4 receptor deficiency: Lastly, loss-of-function variants in SRRM2 have been described by Cuinat et al. in 2022 to cause a neurodevelopmental disorder with facial dysmorphisms that is associated with overweight/obesity.